What are you looking for?

Showing 9 of 79 Results in Insurance

Health Care Reform, Reconciliation, and the Role of the Senate: Some Wise Counsel from Key Democrats

TOTM Well, it looks like Congress is going to attempt to enact the Senate’s health care bill using the reconciliation process. President Obama certainly suggested as . . .

Well, it looks like Congress is going to attempt to enact the Senate’s health care bill using the reconciliation process. President Obama certainly suggested as much in Thursday’s Health Care Summit, downplaying the significance of such a move and suggesting it may be necessary in order to “move forward.”

Read the full piece here

Continue reading
Financial Regulation & Corporate Governance

Here Come the Price Controls

TOTM As Todd mentioned, the Obama Administration has released its latest plan for regulating (and mandating) health insurance. The new plan includes a novel element: the . . .

As Todd mentioned, the Obama Administration has released its latest plan for regulating (and mandating) health insurance. The new plan includes a novel element: the creation of a seven-member Health Insurance Rate Authority that would issue an annual schedule of “reasonable” rate increases. Increases deemed unjustified could be blocked, and insurers that imposed unjustified rate increases would have to provide rebates to overcharged consumers.

Read the full piece here

Continue reading
Financial Regulation & Corporate Governance

Thoughts on ‘The Small Bill’

TOTM Writing in the Weekly Standard, Jeffrey Anderson offers an alternative to Obamacare (or should we call it Pelosireidcare?). The seven provisions in the “Small Bill” . . .

Writing in the Weekly Standard, Jeffrey Anderson offers an alternative to Obamacare (or should we call it Pelosireidcare?). The seven provisions in the “Small Bill” seem sensible to this nonexpert. Allowing insurance to be sold interstate is likely to bring down costs and improve service — wouldn’t some competition from Geico Health Insurance be a good thing? I can already imagine the commercials. Another proposal is to cap noneconomic damages in medical malpractice suits. Again, this seems like a no-brainer.

Read the full piece here.

Continue reading
Financial Regulation & Corporate Governance

A Defense of the Insurance Industry Antitrust Exemption?

TOTM The subject of antitrust exemptions has been an oft-discussed topic here at TOTM (see, e.g. here and here).  In the latter of those two links . . .

The subject of antitrust exemptions has been an oft-discussed topic here at TOTM (see, e.g. here and here).  In the latter of those two links I was somewhat critical of the DOJ for taking a neutral stance on the insurance industry exemption, which has now become rather wrapped up in the health care reform debate. I wrote…

Read the full piece here

Continue reading
Antitrust & Consumer Protection

Paul Krugman is a partisan hack

TOTM Occasionally I read Mr. Krugman’s column for entertainment purposes — sort of like watching Project Runway or Animals Gone Wild. This morning was one of . . .

Occasionally I read Mr. Krugman’s column for entertainment purposes — sort of like watching Project Runway or Animals Gone Wild. This morning was one of those occasions. The man is a partisan hack of the worst sort. Why does anyone take his political observations seriously?

Read the full piece here.

Continue reading
Innovation & the New Economy

What Am I Missing About Antitrust Exemptions?

TOTM Geoff mentions the pending bills on the Hill that would grant merchants an antitrust exemption to negotiate interchange fees.  The insurance industry exemption has also . . .

Geoff mentions the pending bills on the Hill that would grant merchants an antitrust exemption to negotiate interchange fees.  The insurance industry exemption has also been in the news of late in the wake of the Democrats’ threats of repeal.  Here’s what I’m puzzled about.  Other than self-interested parties that have a lot to gain from an exemption (I’d like an exemption from income taxes if anybody cares), why won’t anybody say that industry exemptions from the Sherman Act price-fixing prohibitions are decidedly not a good thing for consumers?

Read the full piece here.

Continue reading
Antitrust & Consumer Protection

Will the Public Insurance Plan Be a Predator?

TOTM Wall Street Journal columnist Thomas Frank inhabits a simple little world in which private enterprise, in its relentless pursuit of profit (i.e., charging more for . . .

Wall Street Journal columnist Thomas Frank inhabits a simple little world in which private enterprise, in its relentless pursuit of profit (i.e., charging more for something than it’s worth), is consistently a force for evil, and government, populated by wise and benevolent folk who have eschewed riches in favor of public service (see, e.g., Ted Kennedy), is always a force for good. Responding to Mr. Frank’s simple-minded musings is generally like shooting fish in a barrel, so I normally just leave him alone. This week, though, I feel compelled to respond.

Read the full piece here.

Continue reading
Innovation & the New Economy

How Competitive Is the Health Insurance Market, Really?

TOTM Not very, according to the President in his recent health care speech, making the case that lack of competition and for-profit monopolists are what ails . . .

Not very, according to the President in his recent health care speech, making the case that lack of competition and for-profit monopolists are what ails the health care market…

Read the full piece here.

Continue reading
Antitrust & Consumer Protection

Thaler’s Unsound Argument About the Public Insurance Option

TOTM University of Chicago economist (and behavioralist doyen) Richard Thaler thinks “the question of whether a ‘public option’ should be part of the health care solution” . . .

University of Chicago economist (and behavioralist doyen) Richard Thaler thinks “the question of whether a ‘public option’ should be part of the health care solution” is just “one big distraction.” In Sunday’s New York Times, Thaler argues that the debate over the public option is a “red herring” if, as President Obama insists, the public plan will have to break even and won’t be granted “the power to impose special deals with suppliers like hospitals and drug companies.” If those two conditions are satisfied, Thaler contends, the public plan is unlikely to have much success and certainly won’t drive out private insurers.

Read the full piece here.

Continue reading
Antitrust & Consumer Protection